MIM
VINCW

Monashee Investment Management’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

Monashee Investment Management’s Portfolio VINCW Stock Details VINCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200,000
Closed -$660K – 513
2020
Q4 		$660K Buy
+200,000
New +$665K 0.09% 179

Other funds holding VINCW

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Monashee Investment Management's VINCW Position: Q1 2021 in Review

Monashee Investment Management sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q1 2021, closing a stake of 200,000 shares — an estimated $660K sold.

Monashee Investment Management first reported a position in VINCW in Q4 2020 and held it in 1 quarter. The position peaked at $660K in Q4 2020. 17 funds tracked by Wall St. Rank hold VINCW as of Q1 2021.

  • Monashee Investment Management reported no remaining Vincerx Pharma, Inc. Warrant position as of Q1 2021 after selling out during the quarter.
  • Monashee Investment Management sold 200,000 Vincerx Pharma, Inc. Warrant shares in Q1 2021, an estimated $660K.
  • Monashee Investment Management first reported a position in Vincerx Pharma, Inc. Warrant in Q4 2020 and held it in 1 quarter.
  • Monashee Investment Management's Vincerx Pharma, Inc. Warrant position peaked at $660K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q1 2021.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.